Validation overview of bio-analytical methods

Gene Therapy

Volumn 12, Issue , 2005, Pages S131-S138

  Tuomela, M ^a   Stanescu, I ^a   Krohn, K ^a  

^a FIT Biotech Plc   (Finland)

Author keywords

Biological methods; GLP; GMP; Validation

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GENE PRODUCT; PLASMID DNA; VIRUS PROTEIN;

ANALYTICAL PARAMETERS; CONFERENCE PAPER; DRUG SCREENING; ENZYME LINKED IMMUNOSPOT ASSAY; GENE THERAPY; GOOD CLINICAL PRACTICE; GOOD MANUFACTURING PRACTICE; LIMULUS LYSATE TEST; MEDICAL LITERATURE; METHODOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; PROTEIN MICROARRAY; STANDARDIZATION; VALIDATION PROCESS; VIRAL GENE DELIVERY SYSTEM;

BIOLOGICAL ASSAY; BIOTECHNOLOGY; GENE THERAPY; GENETIC TECHNIQUES; HUMANS; IMMUNOASSAY; REPRODUCIBILITY OF RESULTS;

LIMULUS;

EID: 27544439701     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302627     Document Type: Article

References (27)

1. The United States Pharmacopeial Convention Inc. Cell and Gene Therapy Products. US Pharmacopeia: Rockville, 2004, pp 2550–2578.
2. The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit. Note for Guidance on Validation of Analytical Methods: Definitions and Terminology. London, 1994, CPMPlICHl381l95.
3. The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit. Note for Guidance on Validation of Analytical Procedures: Methodology. London, 1996, CPMPlICHl281l95.
4. Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Center for Veterinary Medicine (CVM). Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services: Rockville, 2001.
5. The European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit. Note for Guidance on Specifications: Test Procedures and Acceptance Criteria for Biotechnologicall Biological Products. London, 1999, CPMPlICHl365l96.
6. The fitness for purpose of analytical methods. Eurachem Guidance Document No. 1lWELAC Guidance Document No. WGD 2: guidance on the interpretation of the EN 45000 series of standards and ISOlIEC Guide 25, 1993.
7. Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via polymerase-catalyzed chain reaction. Methods Enzymol 1987; 155: 335–350.
8. Saiki KR et al. Primer-directed enzymatic amplification of DNA with thermostabile DNA polymerase. Science 1988; 239: 487–491.
9. Neumaier M, Braun A, Wagener C. Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics. Clin Chem 1998; 44: 12–26.
10. Sedgwick JD, Holt PG. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J Immunol Methods 1983; 57: 301–309.
11. Czerkinsky CC et al. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 1983; 65: 109–121.
12. Olive M, Eisenlohr LC, Flomenberg P. Quantitative analysis of adenovirus-specific CD4+ T-cell responses from healthy adults. Viral Immunol 2001; 14: 403–413.
13. Smith JG et al. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus. Clin Diagn Lab Immunol 2001; 8: 871–879.
14. Woodberry T et al. Prime boost vaccination strategies: CD8 T cell numbers, protection and Th1 bias. J Immunol 2003; 170: 2599–2604.
15. Engvall E, Perlmann P. Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol 1972; 109: 129–135.
16. Alwine JC, Kemp DJ, Stark GR. Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethylpaper and hybridization with DNA probes. Proc Natl Acad Sci USA 1977; 74: 5350–5354.
17. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350–4354.
18. Schena M et al. Parallel human genome analysis: microarraybased expression monitoring of 1000 genes. Proc Natl Acad Sci USA 1996; 93: 10614–10619.
19. Howard KA et al. Formulation of a microparticle carrier for oral polyplex-based DNA vaccines. Biochim Biophys Acta 2004; 1674: 149–157.
20. Ohlfest JR, Lobitz PD, Perkinson SG, Largaespada DA. Integration and long-term expression in xenografted human glioblastoma call using a plasmid-based trasposon system. Mol Ther 2004; 10: 260–268.
21. Min KA, Lee SK, Kim CK. Improved gene expression pattern using Epstein–Barr virus (EBV)-based plasmid and cationic emulsion. Biomaterials 2005; 26: 1063–1070.
22. Barrett JC, Kawasaki ES. Microarrays: the use of oligonucleotide and cDNA for the analysis of gene expression. Drug Discov Today 2003; 8: 134–141.
23. Brazma A et al. Minimum information about a microarray experiment (MIAME) – toward standards for microarray data. Nat Genet 2001; 29: 365–371.
24. Council of Europe. Pyrogens. European Pharmacopoeia: Strasbourg, 2004, p 152.
25. The United States Pharmacopeial Convention Inc. Pyrogen Test. US Pharmacopeia: Rockville, 2004, pp 2289–2290.
26. The United States Pharmacopeial Convention Inc. Bacterial Endotoxins Test. US Pharmacopeia: Rockville, 2004, pp 2264–2267.
27. Council of Europe. Bacterial Endotoxins. European Pharmacopoeia: Strasbourg, 2004, pp 161–168.